Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-30,126
Closed -$738K 846
2020
Q1
$738K Hold
30,126
0.01% 681
2019
Q4
$755K Sell
30,126
-17,451
-37% -$393K 0.01% 698
2019
Q3
$1.01M Buy
47,577
+43
+0.1% +$917 0.01% 605
2019
Q2
$1.05M Sell
47,534
-994
-2% -$24K 0.01% 644
2019
Q1
$1.29M Buy
48,528
+905
+2% +$25.7K 0.02% 579
2018
Q4
$1.22M Sell
47,623
-1,874
-4% -$64.8K 0.02% 548
2018
Q3
$2.13M Sell
49,497
-93
-0.2% -$4.16K 0.03% 493
2018
Q2
$2.15M Sell
49,590
-343
-0.7% -$13.9K 0.03% 469
2018
Q1
$1.84M Buy
49,933
+28,175
+129% +$1.03M 0.03% 495
2017
Q4
$784K Sell
21,758
-27,264
-56% -$922K 0.01% 623
2017
Q3
$1.75M Buy
49,022
+1,788
+4% +$58.4K 0.03% 481
2017
Q2
$1.56M Hold
47,234
0.03% 505
2017
Q1
$1.89M Buy
47,234
+6,123
+15% +$239K 0.04% 458
2016
Q4
$1.54M Sell
41,111
-625
-1% -$22.8K 0.04% 418
2016
Q3
$1.53M Sell
41,736
-54,013
-56% -$1.81M 0.04% 409
2016
Q2
$3.22M Buy
95,749
+47,950
+100% +$1.54M 0.08% 242
2016
Q1
$1.48M Buy
47,799
+385
+0.8% +$11.8K 0.04% 368
2015
Q4
$1.59M Sell
47,414
-229,438
-83% -$8.53M 0.04% 331
2015
Q3
$10.4M Sell
276,852
-11,721
-4% -$479K 0.26% 117
2015
Q2
$13.9M Sell
288,573
-26,965
-9% -$1.39M 0.29% 97
2015
Q1
$15.8M Buy
315,538
+134,609
+74% +$7.3M 0.32% 77
2014
Q4
$11.9M Buy
+180,929
New +$12.6M 0.25% 124

Other funds holding NOV

Candriam SCA's NOV Position: Q2 2020 in Review

Candriam SCA sold out of NOV (NOV) in Q2 2020, closing a stake of 30,126 shares — an estimated $738K sold.

Candriam SCA first reported a position in NOV in Q4 2014 and held it in 22 quarters. The position peaked at $15.8M in Q1 2015. 428 funds tracked by Wall St. Rank hold NOV as of Q2 2020.

  • Candriam SCA reported no remaining NOV position as of Q2 2020 after selling out during the quarter.
  • Candriam SCA sold 30,126 NOV shares in Q2 2020, an estimated $738K.
  • Candriam SCA first reported a position in NOV in Q4 2014 and held it in 22 quarters.
  • Candriam SCA's NOV position peaked at $15.8M in Q1 2015.
  • 428 funds tracked by Wall St. Rank held NOV as of Q2 2020.

Based on Candriam SCA's 13F filing for Q2 2020, filed 23 Jul 2020.